Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Tenofovir disoproxil fumarate (300mg)
Therapeutic Category
Gynecology and Fertility, Antiviral
Dosage Form
Tablet
Packaging Type
Bottle
Packaging
30 Tablets
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tenofit 300 Tablet (Tenofovir Disoproxil Fumarate 300mg) is a once-daily antiretroviral tablet indicated for the treatment of HIV infection and chronic Hepatitis B. Tenofovir Disoproxil Fumarate inhibits viral reverse transcriptase, preventing viral replication and improving immune function.
It is widely prescribed by infectious disease specialists, HIV clinics, and hepatologists, ensuring high institutional and hospital demand. Tenofit 300 Tablet offers a profitable PCD pharma franchise opportunity, ideal for B2B distribution, manufacturing, and export, serving the growing antiretroviral therapy market.
Common side effects may include nausea, diarrhea, headache, dizziness, or fatigue. Rarely, it may cause renal impairment, lactic acidosis, or liver function abnormalities. Patients should seek immediate medical attention if experiencing severe abdominal pain, unusual tiredness, or jaundice.
Tenofit 300 Tablet is indicated for the treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (cART). It is also indicated for chronic Hepatitis B infection in adults requiring antiviral therapy. The tablet helps in reducing viral load, increasing CD4 counts, and lowering the risk of disease progression.
Take Tenofit 300 Tablet exactly as prescribed, usually once daily with or without food. Adherence to the prescribed regimen is critical to prevent viral resistance. Patients with renal or liver impairment should use this medication under close medical supervision. Adequate hydration should be maintained during therapy.
Store Tenofit 300 Tablet in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children and do not use after the expiry date mentioned on the packaging.
Composition : Diclofenac (100mg)
Composition : Diclofenac (50mg) + Metaxalone (400mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
Composition : Diclofenac (50mg) + Serratiopeptidase (10mg)
Composition : Piroxicam (20mg) Tablet
Composition : Indomethacin (75mg)
Composition : Polmacoxib (2mg)
Composition : Diclofenac (75mg/ml)
Composition : Piroxicam (20mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tenofovir Disoproxil Fumarate IP 300mg Tablet has strong demand in the antiviral, infectious disease, HIV care, and hepatology segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on specialty and chronic disease portfolios.
Medical distributors and agencies can benefit from consistent demand for antiviral therapy under specialist medical supervision. Tenofovir Disoproxil Fumarate IP 300mg is an antiviral medication belonging to the nucleotide reverse transcriptase inhibitor (NRTI) class Commonly prescribed as part of combination antiretroviral therapy (ART) for HIV-1 infection and for the treatment of chronic Hepatitis B virus (HBV) infection, as advised by healthcare professionals Helps suppress viral replication, supporting long-term disease management and reducing the risk of disease progression when used as prescribed Oral tablet formulation provides convenient once-daily administration and promotes patient adherence to long-term treatment plans Requires regular monitoring of kidney function, liver function, bone health, and overall treatment response during therapy Frequently utilized in ART centers, infectious disease clinics, hepatology departments, hospitals, and specialty healthcare facilities Widely prescribed by infectious disease specialists, hepatologists, HIV specialists, and general physicians involved in antiviral care This strengthens a comprehensive antiviral, HIV care, and hepatology portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tenofovir Disoproxil Fumarate IP 300mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, long-term patient usage, specialty healthcare market opportunities, reliable supply chain support, repeat procurement requirements, and attractive margins in the antiviral segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise